ADAPTIVE BIOTECHNOLOGIES CORPORATION Debt Securities, Available-for-sale, Amortized Cost
ADAPTIVE BIOTECHNOLOGIES CORPORATION (ADPT) had Debt Securities, Available-for-sale, Amortized Cost of $374.16 million as of 2019-06-30, per its 10-Q filed 2019-08-13.
Discontinued › Notes
us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis · last filed 2019-08-13
- 2019-06-30: Debt Securities, Available-for-sale, Amortized Cost $374.16M.
- 2018-12-31: Debt Securities, Available-for-sale, Amortized Cost $110.09M.
| Period end | Debt Securities, Available-for-sale, Amortized Cost |
|---|---|
| 2019-06-30 | $374.16M 10-Q · filed 2019-08-13 |
| 2018-12-31 | $110.09M 10-Q · filed 2019-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |